These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25632743)

  • 1. [Effect of treatment for hypocellular myelodysplastic syndromes by a low dose qinghuang powder combined with Chinese drugs for Shen supplementing and Pi invigorating: a clinical observation].
    Zhou QB; Wang HZ; Gao F; Tang XD; Xu S; Yang XH; Xu YG; Hu XM; Ma R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec; 34(12):1444-8. PubMed ID: 25632743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of treatment for myelodysplastic syndrome by Qinghuang Powder combined with Chinese herbs for reinforcing shen and strenghening pi].
    Xu S; Hu XM; Xu YG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Mar; 28(3):216-8. PubMed ID: 18476419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Qinghuang Powder combined Chinese herbs for Pi-strengthening and Shen-reinforcing on HIF-1alpha in bone marrow mononuclear cells of myelodysplastic syndrome patients: an experimental research].
    Gao F; Xu YG; Yang XH; Ma R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):174-8. PubMed ID: 24672941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Qinghuang Powder () Combined with Bupi Yishen Decoction () in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation.
    Zhou QB; Yang XH; Wang HZ; Wang DX; Xu YG; Hu XM; Xu FQ; Ma R
    Chin J Integr Med; 2019 May; 25(5):354-359. PubMed ID: 29500545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of Blood Arsenic Concentration with Effect and Safety of Arsenic-Containing Qinghuang Powder () in Patients with Myelodysplastic Syndrome.
    Deng ZY; Zhu SR; Wang MJ; Fang S; Zhao P; Zhu QZ; Wang HZ; Guo XQ; Xu YG; Yi BW; Shang XH; Ma R; Hu XM
    Chin J Integr Med; 2019 Jul; 25(7):497-501. PubMed ID: 31278627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of oligospermia/asthenozoospermia patients by three different Chinese medical principles: a randomized control clinical study].
    Guo J; Wang F; Zhang Q; Geng Q; Yu GJ; Zhao JY; Gao QH; Song CS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1170-3. PubMed ID: 24273967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of qinghuang power combined Chinese herbs for shen reinforcing and Pi strengthening on activated T cells of myelodysplastic syndrome patients].
    Gao F; Ma R; Yang XH; Xu YG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):443-7. PubMed ID: 23841258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Gene Mutations with Response to Arsenic-Containing Compound Qinghuang Powder () in Patients with Myelodysplastic Syndromes.
    Zhao P; Liang JB; Deng ZY; Wang MJ; Qin JY; Chen CJ; Hu XM
    Chin J Integr Med; 2019 Jun; 25(6):409-415. PubMed ID: 29619748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic outcomes of myelodysplastic syndromes treatment with hypomethylating agents in community practice.
    Bordoni RE; Feinberg BA; Gilmore JW; Haislip S; Jackson JH; Farrelly E; Kim E; Buchner D
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):350-4. PubMed ID: 21816373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic primary glomerulopathy patients of Shen deficiency and dampness heat syndrome by yishen qingli granule combined low-dose Tripterygium wilfordii multiglycoside tablet: a clinical efficacy observation].
    Sheng MX; Sun W; Xing CY; Yuan FH; Tang SF; Xiong PH; Ma JP; Zhou D; Gao K; Jiang Y; Chen JH; Mao HJ; Mou J; Luo YZ; Wei MG; Liu CX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1636-41. PubMed ID: 24517060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Arsenic-Containing Qinghuang Powder: A Potential Drug for Myelodysplastic Syndromes.
    Ming J; Liu WY; Xiao HY; Xu YG; Ma R; Hu XM
    Chin J Integr Med; 2022 Aug; 28(8):762-768. PubMed ID: 32146594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical observation of the treatment of myelodysplastic syndrome mainly with Qinghuang Powder.
    Xu S; Ma R; Hu XM; Xu YG; Yang XH; Wang HZ; Sun SZ; Liu F
    Chin J Integr Med; 2011 Nov; 17(11):834-9. PubMed ID: 22057412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of TCM syndrome-typing based therapy combined with cyclosporin in treating myelodysplastic syndrome].
    Liu L; Shu X; Hu NP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):933-5. PubMed ID: 17121049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
    Vey N; Bosly A; Guerci A; Feremans W; Dombret H; Dreyfus F; Bowen D; Burnett A; Dennis M; Ribrag V; Casadevall N; Legros L; Fenaux P
    J Clin Oncol; 2006 Jun; 24(16):2465-71. PubMed ID: 16651646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic Dispensing Powder Promotes Erythropoiesis in Myelodysplastic Syndromes via Downregulation of HIF1A and Upregulation of GATA Factors.
    Fan T; Feng X; Yokota A; Liu W; Tang Y; Yan X; Xiao H; Wang Y; Deng Z; Zhao P; Wang M; Wang H; Ma R; Hu X; Huang G
    Am J Chin Med; 2021; 49(2):461-485. PubMed ID: 33641653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the traditional Chinese medicine compound Yisui Lixue decoction on apoptosis of marrow cells in rats with myelodysplastic syndrome induced by 
dimethyl benzanthracene].
    Huang Y; Xiong D; Xu Y; Yu J; Xian Y; Cai E
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):26-34. PubMed ID: 28216494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of myelodysplastic syndrome by hematopoietic stem cell transplantation combined with Chinese medical syndrome typing: a clinical study].
    Zhang Y; Ye BD; Qian LL; Gao YT; Wen XW; Shen JP; Zhou YH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jan; 35(1):53-6. PubMed ID: 25790675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observation on treatment of myelodysplastic syndromes with yisuikang].
    Guo PJ; Li GZ; Liu PL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Feb; 15(2):74-6. PubMed ID: 7787394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
    Lu J; Jin J; Xu WL
    Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation on treatment of premature ovarian failure patients of shen deficiency gan stagnation syndrome by combination of bushui roumu recipe and medroxyprogesterone acetate tablet HUA].
    Hua FF; Xia YH; Yang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Aug; 32(8):1028-31. PubMed ID: 23173246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.